- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
From Benzinga
The Health of the Healthcare System
August 13, 2025
From Stock Gumshoe
Midsummer Shorties from Doc Gumshoe
July 17, 2025
From Stock Gumshoe
This one daily habit can boost brain health and help lower risk of dementia—it's 'very overlooked,' longevity doctor says
June 17, 2025
From CNBC.com News
Alzheimer’s Update and Late Winter Miscellany
March 17, 2025
From Stock Gumshoe
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
November 25, 2024
Tickers
SAVA
From Benzinga
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
From CNBC.com News
Shark Tank's Barbara Corcoran Reveals Her Struggle With Alzheimer's In Her Family
September 28, 2024
Tickers
NEWS
From Benzinga
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
From CNBC.com News
Midsummer News Flashes – Good and Not So Good
August 14, 2024
From Stock Gumshoe
Alzheimer’s and Parkinson’s Tests and Treatments… plus a Quick COVID-19 (and Long COVID) Update
July 25, 2024
From Stock Gumshoe
From Benzinga
From Benzinga
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
From CNBC.com News
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
June 21, 2024
From Benzinga
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
February 09, 2024
From CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
From Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
December 04, 2023
Tickers
CBD
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
From Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
September 30, 2023
From CNBC.com News
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
August 03, 2023
From CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
From Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
July 20, 2023
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.